Status:
NOT_YET_RECRUITING
Evaluation of a Supervised Clinical Feeding Intervention
Lead Sponsor:
Boston Children's Hospital
Conditions:
Peanut Allergies in Children
Eligibility:
All Genders
4-6 years
Phase:
NA
Brief Summary
Peanut allergies affect approximately 2.5% of children; are associated with significant mortality, morbidity, and economic costs; and often lead to persistent peanut allergies in adulthood. We now kno...
Detailed Description
TITLE: A Randomized Control Trial of a Supervised Peanut Feeding Clinic to Increase Early Peanut Introduction A. Specific Aims/Objectives We aim to assess if a supervised peanut feeding clinic within ...
Eligibility Criteria
Inclusion
- All 4-6 month infants who feed by mouth who have not introduced peanuts yet and have no evidence of peanut allergy.
- \-
Exclusion
- Non-English speaking, not eating solid food, evidence of peanut allergy.
- \-
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT06892132
Start Date
May 1 2025
End Date
August 31 2027
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115